243 related articles for article (PubMed ID: 29361459)
1. Extended use of bemiparin as thromboprophylaxis during bariatric surgery: results of anti-factor Xa activity measurements.
Muñoz-Atienza V; Gil-Rendo A; Amo-Salas M; Núñez-Guerrero P; Martín-Fernández J
Surg Obes Relat Dis; 2018 Mar; 14(3):354-360. PubMed ID: 29361459
[TBL] [Abstract][Full Text] [Related]
2. Effect of prophylactic dalteparin on anti-factor Xa levels in morbidly obese patients after bariatric surgery.
Simoneau MD; Vachon A; Picard F
Obes Surg; 2010 Apr; 20(4):487-91. PubMed ID: 18931882
[TBL] [Abstract][Full Text] [Related]
3. Assessment of empiric body mass index-based thromboprophylactic dosing of enoxaparin after bariatric surgery: evidence for dosage adjustment using anti-factor Xa in high-risk patients.
Karas LA; Nor Hanipah Z; Cetin D; Schauer PR; Brethauer SA; Daigle CR; Aminian A
Surg Obes Relat Dis; 2021 Jan; 17(1):153-160. PubMed ID: 33046419
[TBL] [Abstract][Full Text] [Related]
4. Are We Missing Treatment Standards for Thromboprophylaxis of the Obese and Super-Obese Patient Population? A Prospective Systematic Cohort Study.
Stier C; Koschker AC; Stier R; Sosnierz A; Chiappetta S
Obes Surg; 2020 May; 30(5):1704-1711. PubMed ID: 31974866
[TBL] [Abstract][Full Text] [Related]
5. A Single-Center Comparison of Extended and Restricted THROMBOPROPHYLAXIS with LMWH after Metabolic Surgery.
Leeman M; Biter LU; Apers JA; Birnie E; Verbrugge S; Verhoef C; Dunkelgrun M
Obes Surg; 2020 Feb; 30(2):553-559. PubMed ID: 31641983
[TBL] [Abstract][Full Text] [Related]
6. Use of Enoxaparin in Obese Adolescents During Bariatric Surgery--a Pilot Study.
Mushtaq A; Vaughns JD; Ziesenitz VC; Nadler EP; van den Anker JN
Obes Surg; 2015 Oct; 25(10):1869-74. PubMed ID: 25716128
[TBL] [Abstract][Full Text] [Related]
7. Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity.
Borkgren-Okonek MJ; Hart RW; Pantano JE; Rantis PC; Guske PJ; Kane JM; Gordon N; Sambol NC
Surg Obes Relat Dis; 2008; 4(5):625-31. PubMed ID: 18261965
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics of low molecular weight heparin in patients undergoing bariatric surgery: a prospective, randomised study comparing two doses of parnaparin (BAFLUX study).
Imberti D; Legnani C; Baldini E; Cini M; Nicolini A; Guerra M; De Paoli M; Zanardi A; Palareti G
Thromb Res; 2009 Dec; 124(6):667-71. PubMed ID: 19482341
[TBL] [Abstract][Full Text] [Related]
9. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
10. Lean body weight is the best scale for venous thromboprophylaxis algorithm in severely obese patients undergoing bariatric surgery.
Gaborit B; Moulin PA; Bege T; Boullu S; Vincentelli C; Emungania O; Morange PE; Berdah S; Salem JE; Dutour A; Frere C
Pharmacol Res; 2018 May; 131():211-217. PubMed ID: 29452290
[TBL] [Abstract][Full Text] [Related]
11. Perioperative thromboprophylaxis in severely obese patients undergoing bariatric surgery: insights from a French national survey.
Moulin PA; Dutour A; Ancel P; Morange PE; Bege T; Ziegler O; Berdah S; Frère C; Gaborit B
Surg Obes Relat Dis; 2017 Feb; 13(2):320-326. PubMed ID: 27720420
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of unfractionated and low-molecular-weight heparin for prevention of venous thromboembolism following bariatric surgery.
Birkmeyer NJ; Finks JF; Carlin AM; Chengelis DL; Krause KR; Hawasli AA; Genaw JA; English WJ; Schram JL; Birkmeyer JD;
Arch Surg; 2012 Nov; 147(11):994-8. PubMed ID: 23165612
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Anti-factor Xa Levels in Female and Male Patients with Obesity After Enoxaparin Application for Thromboprophylaxis.
Wagner J; Wruck H; Lautenbach A; von Kroge P; Wolter S; Mann O; Izbicki J; Duprée A
Obes Surg; 2022 Mar; 32(3):861-867. PubMed ID: 34988894
[TBL] [Abstract][Full Text] [Related]
14. The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial.
Steele KE; Canner J; Prokopowicz G; Verde F; Beselman A; Wyse R; Chen J; Streiff M; Magnuson T; Lidor A; Schweitzer M
Surg Obes Relat Dis; 2015; 11(3):672-83. PubMed ID: 25620436
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis of thromboembolism in bariatric surgery with parnaparin.
Forestieri P; Quarto G; De Caterina M; Cuocolo A; Pilone V; Formato A; Ruocco A; Ferrari P
Obes Surg; 2007 Dec; 17(12):1558-62. PubMed ID: 18004632
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolism in burns patients: Are we underestimating the risk and underdosing our prophylaxis?
Lu P; Harms KA; Paul E; Bortz H; Lo C; Cleland H
J Plast Reconstr Aesthet Surg; 2021 Aug; 74(8):1814-1823. PubMed ID: 33414092
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Obesity on Anti-Xa Concentrations in Bariatric Patients.
Schijns W; Deenen MJ; Aarts EO; Homan J; Janssen IMC; Berends FJ; Kaasjager KAH
Obes Surg; 2018 Jul; 28(7):1997-2005. PubMed ID: 29404935
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Anti-Factor Xa Levels of Patients Undergoing Colorectal Surgery Given Once-Daily Enoxaparin Prophylaxis: A Clinical Study Examining Enoxaparin Pharmacokinetics.
Pannucci CJ; Fleming KI; Bertolaccini CB; Prazak AM; Huang LC; Pickron TB
JAMA Surg; 2019 Aug; 154(8):697-704. PubMed ID: 31116389
[TBL] [Abstract][Full Text] [Related]
19. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
[TBL] [Abstract][Full Text] [Related]
20. Fixed-dose enoxaparin after bariatric surgery: the influence of body weight on peak anti-Xa levels.
Celik F; Huitema AD; Hooijberg JH; van de Laar AW; Brandjes DP; Gerdes VE
Obes Surg; 2015 Apr; 25(4):628-34. PubMed ID: 25223871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
